Embracing diversity in clinical trials
At Boehringer Ingelheim, we understand the crucial need of embracing diversity in clinical trials as an opportunity to enable more equitable healthcare.
Search
The power of patient advocacy in cancer care
Larry, a retired US Navy veteran, and Jeff, UICC President, have more in common than a cancer diagnosis: they share a passion for patient empowerment.
Open Innovation at Boehringer Ingelheim
Learn more about how we’re working across the innovation community to advance research and accelerate the development of new medicines
The unseen lameness problem in horses
Learn more about the signs, causes and preventive measures of lameness in horses.
On the path to decarbonization: How we reduce our emissions
How our sites Fornovo and Paulínia became carbon-neutral and support our recently SBTi-validated 2030 goals
History video
Learn more about the history of the innovative pharmaceutical company Boehringer Ingelheim
Keep water clean
Human beings can’t survive without water. Further, the safe production of medicines depends on clean drinking water.
Five ways to include more diversity in clinical trials
Making More Health at a Glance.pdf
Making More Health - CREATE - Magazine Social Entrepreneurship - Edition 2023
Small Cell Lung Cancer
Discover more about small cell lung cancer, including its symptoms and treatment options.
DiaTEC new purification technology Ingelvac CircoFLEX
Boehringer Ingelheim introduces DiaTEC, a new and proprietary purification technology for Ingelvac CircoFLEX®
About cardio-renal-metabolic conditions
This page provides an overview of cardiovascular, renal, and metabolic conditions
Over 100 billion birds vaccinated with VAXXITEK
Boehringer Ingelheim celebrates that over 100 billion birds have been vaccinated with VAXXITEK® HVT + IBD in October 2018.
Drug Discovery Process
world rabies day 2019
world rabies day 2019
Non-small cell lung cancer
Discover more about non-small cell lung cancer, including its symptoms and treatment options.
Boehringer Ingelheim Social Engagements
Boehringer Ingelheim Social Engagements Contributes to company commitment to impact 50 million people in vulnerable communities by 2030 through supporting social entrepreneurs and innovative solutions
Co-creation with Communities
Making More Health has launched co-creation projects in Asia, Africa, Europe and other localities around the world with top social entrepreneurs.
A Unique Bond: by my side
Caroline’s remarkable bond with Snowball helped her cope better with COPD and maintain a more independent life.
Supporting local communities by offsetting carbon emissions
Boehringer Ingelheim partially offsets its carbon emissions by partnering with ClimateSeed
Our Stories
Find out more about us by reading our stories. Below are the latest press releases, news stories, and more from our family around the world.
Boehringer receives SBTi validation for CO2 reduction targets
Boehringer Ingelheim receives SBTi validation for CO2 reduction targets
Building blocks of our future
Our global investment projects are the building blocks for improved healthcare and sustainability
Inauguration of new global center for veterinary vaccine R&D
Inauguration of a new global hi-tech centre for biological research and development in Lyon.